Skip to main content
Log in

Surgical ovarian ablation cost effective versus GnRH

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Ferrandina G, et al. Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment. Clinical Drug Investigation : 11 Sep 2017. Available from: URL: http://doi.org/10.1007/s40261-017-0571-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Surgical ovarian ablation cost effective versus GnRH. PharmacoEcon Outcomes News 787, 35 (2017). https://doi.org/10.1007/s40274-017-4363-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4363-3

Navigation